AVITA Medical, Inc. (RCEL)
9.92
-0.14
(-1.39%)
USD |
NASDAQ |
Aug 24, 16:00
9.92
0.00 (0.00%)
After-Hours: 19:58
AVITA Medical Market Cap : 306.79M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 311.12M |
| August 20, 2026 | 312.05M |
| August 19, 2026 | 319.78M |
| August 18, 2026 | 304.63M |
| August 17, 2026 | 244.32M |
| August 14, 2026 | 242.78M |
| August 13, 2026 | 247.72M |
| August 12, 2026 | 251.13M |
| August 11, 2026 | 253.60M |
| August 10, 2026 | 235.04M |
| August 07, 2026 | 240.30M |
| August 06, 2026 | 146.90M |
| August 05, 2026 | 138.24M |
| August 04, 2026 | 143.19M |
| August 03, 2026 | 142.19M |
| July 31, 2026 | 135.42M |
| July 30, 2026 | 138.19M |
| July 29, 2026 | 136.65M |
| July 28, 2026 | 141.88M |
| July 27, 2026 | 146.19M |
| July 24, 2026 | 141.88M |
| July 23, 2026 | 141.88M |
| July 22, 2026 | 152.04M |
| July 21, 2026 | 156.65M |
| July 20, 2026 | 158.19M |
| Date | Value |
|---|---|
| July 17, 2026 | 156.96M |
| July 16, 2026 | 153.27M |
| July 15, 2026 | 145.57M |
| July 14, 2026 | 123.72M |
| July 13, 2026 | 121.57M |
| July 10, 2026 | 124.95M |
| July 09, 2026 | 135.73M |
| July 08, 2026 | 143.11M |
| July 07, 2026 | 153.88M |
| July 06, 2026 | 159.73M |
| July 02, 2026 | 155.73M |
| July 01, 2026 | 143.73M |
| June 30, 2026 | 127.11M |
| June 29, 2026 | 130.80M |
| June 26, 2026 | 122.18M |
| June 25, 2026 | 120.64M |
| June 24, 2026 | 121.57M |
| June 23, 2026 | 120.64M |
| June 22, 2026 | 124.03M |
| June 18, 2026 | 123.41M |
| June 17, 2026 | 121.26M |
| June 16, 2026 | 120.64M |
| June 15, 2026 | 120.95M |
| June 12, 2026 | 120.34M |
| June 11, 2026 | 122.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 12.39B |
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 239.94B |
| Anika Therapeutics, Inc. | 285.19M |
| BioCryst Pharmaceuticals, Inc. | 2.468B |
Market Cap Related Metrics
| PS Ratio | 3.937 |
| Price | 9.92 |
| Earnings Yield | -14.55% |